Dr. Reddy’s to Release Q2 FY17 Results on Oct 25, 2016; Earnings Call Slated for Oct 25, 6.30 PM IST / 9.00 AM EDT

HYDERABAD, India–(BUSINESS WIRE)– Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will
announce results for the Second Quarter ended September 30, 2016 on
Tuesday, October 25, 2016 after the Board Meeting. The results will be
available on the Company’s website www.drreddys.com.

Summary of Events

Earnings Call

Following the release, the management of the Company will host an
earnings call to discuss the Company’s financial performance. (Dial
In and other details given below)

Audio Webcast

The audio webcast of the earnings call will be available to all
interested parties at www.drreddys.com.
Please visit the web site at least fifteen minutes ahead of the
scheduled start time to register and to download and install any
necessary audio software. Participants in the webcast can listen to the
proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through Oct 29^th,
2016. For play back dial in phone No: 022 3065 2322, 022 61813322 and
ID: 375#.

No password/pin number is necessary to dial in to any of the other
calls. As participation in the call is limited, early registration is
encouraged. The operator will provide instructions on asking questions
before and during the call.

About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (BSE: 500124,
NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company,
committed to providing affordable and innovative medicines for healthier
lives. Through its three businesses – Pharmaceutical Services & Active
Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s
offers a portfolio of products and services including APIs, custom
pharmaceutical services, generics, biosimilars and differentiated
formulations. Our major therapeutic areas of focus are gastrointestinal,
cardiovascular, diabetology, oncology, pain management and dermatology.
Dr. Reddy’s operates in markets across the globe. Our major markets
include – USA, Russia & CIS and India. For more information, log on to: www.drreddys.com

Disclaimer: This press release may include statements of future
expectations and other forward-looking statements that are based on the
management’s current views and assumptions and involve known or unknown
risks and uncertainties that could cause actual results, performance or
events to differ materially from those expressed or implied in such
statements. In addition to statements which are forward-looking by
reason of context, the words « may », « will », « should », « expects »,
« plans », « intends », « anticipates », « believes », « estimates », « predicts »,
« potential », or « continue » and similar expressions identify
forward-looking statements. Actual results, performance or events may
differ materially from those in such statements due to without
limitation, (i) general economic conditions such as performance of
financial markets, credit defaults , currency exchange rates , interest
rates , persistency levels and frequency / severity of insured loss
events (ii) mortality and morbidity levels and trends, (iii) changing
levels of competition and general competitive factors, (iv) changes in
laws and regulations and in the policies of central banks and/or
governments, (v) the impact of acquisitions or reorganisation ,
including related integration issues.

The company assumes no obligation to update any information contained
herein.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161014005667/en/